In his new role as chief medical officer, Dr. Gilberstadt will oversee patient care clinical effectiveness at UF St. Johns, according to a June 3 news release from the health system. As interim CEO, Mr. Watson will lead UF Health St. Johns’ integration into the main Gainesvillle, Fla.-based UF Health system.
Dr. Gilberstadt has previously served as a director and substance use treatment physician at Gateway Community Center and chief clinical officer at Ascension St. Vincent’s Medical Center Riverside, both in Jacksonville, Fla., according to his LinkedIn page. Mr. Watson previously served as interim CEO for Maui (Hawaii) Health System.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.